File to download:
Title: Dr. Michael Har-Noy - PowerPoint PPT Presentation
Description: In a preliminary Phase I/II study of AlloStimTM in patients with various solid metastatic tumors, Dr. Michael Har-Noy reported encouraging survival data. Out of the 42 patients studied, Dr. Michael Har-Noy said that the subset of five HER2+ breast cancer patients had a median survival of 416 days – markedly longer than the predicted survival of 60 days or less. These five HER2+ patients had high levels of interleukin 12 – an apparent marker for a positive response. Dr. Michael Har-Noy intends to conduct a pivotal Phase II/III trial of AlloStimTM in metastatic breast cancer patients. – PowerPoint PPT presentation
Download instruction:
When the PPT version of this presentation was uploaded to PowerShow.com, it was checked for
viruses. That said, we cannot guarantee that the PPT file is safe for you to download. But if you
whish to download it, just check that you are not a robot and then click the download button.